NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

Early Phase 1

Completed

Conditions: Hypersensitivity, Immediate

Interventions: Procedure: Nasal Allergen Challenge
Biological: Cat allergen (FelD1)
Other: Environmental Exposure Chamber

First Posted Date: 2014-06-13

Last Posted Date: 2017-09-12

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT02163122

Locations: 🇨🇦
Inflamax Research Inc., Mississauga, Ontario, Canada

Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans

Completed

Conditions: HIV

First Posted Date: 2014-06-03

Last Posted Date: 2025-06-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 90

Registration Number: NCT02154035

Locations: 🇺🇬
Rakai Health Sciences Program Uganda Virus Research Institute, Kalisizo, Uganda

Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States

Terminated

Conditions: Malaria

First Posted Date: 2014-06-03

Last Posted Date: 2019-12-17

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 3

Registration Number: NCT02153996

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

Phase 1

Completed

Conditions: Influenza A Virus, H7N9 Subtype

Interventions: Biological: H7N9 A/Anhui/13 ca influenza virus vaccine
Biological: Inactivated subvirion H7N9 vaccine

First Posted Date: 2014-05-30

Last Posted Date: 2015-03-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 100

Registration Number: NCT02151344

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

PET Imaging and Lymph Node Assessment of IRIS in People With AIDS

Recruiting

Conditions: Immune Reconstitution Inflammatory Syndrome

First Posted Date: 2014-05-26

Last Posted Date: 2025-06-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 300

Registration Number: NCT02147405

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Phase 1

Recruiting

Conditions: HIV Infection

Interventions: Drug: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Drug: Nevirapine (NVP)
Drug: Raltegravir (RAL)
Drug: Lopinavir/Ritonavir (LPV/r)
Drug: VRC01
Drug: VRC07-523LS
Drug: DTG

First Posted Date: 2014-05-16

Last Posted Date: 2025-04-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1120

Registration Number: NCT02140255

Locations: 🇺🇸
4601, University of California, San Diego Clinical Research Site, La Jolla, California, United States
🇺🇸
5048, University of Southern California Clinical Research Site, Los Angeles, California, United States
🇺🇸
5112, David Geffen School of Medicine at UCLA Clinical Research Site, Los Angeles, California, United States

and more 47 locations

Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome

Phase 2

Conditions: Hypereosinophilia
Anti-Asthmatic Agents
Hematologic Diseases
Respiratory System Agents
Leukocyte Disorders

Interventions: Other: Placebo
Drug: benralizumab

First Posted Date: 2014-05-06

Last Posted Date: 2022-02-08

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 20

Registration Number: NCT02130882

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs

Completed

Conditions: Influenza

First Posted Date: 2014-04-28

Last Posted Date: 2019-06-19

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 336

Registration Number: NCT02124096

Locations: 🇺🇸
Ohio State University, College of Veterinary Medicine, Columbus, Ohio, United States

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

Completed

Conditions: Chronic Granulomatous Disease

First Posted Date: 2014-04-17

Last Posted Date: 2025-06-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 137

Registration Number: NCT02116764

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

ADRN Barrier/Immunoprofiling Exploratory Pilot Study

Completed

Conditions: Dermatitis
Eczema
Non-atopic Healthy Controls
Dermatitis, Atopic

First Posted Date: 2014-04-16

Last Posted Date: 2015-07-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 150

Registration Number: NCT02115399

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy